Asia Pacific Biofilms Treatment Market is expected to reach US$ 512.60Mn by 2027

Gauzes and DressingsSegment Held Largest Share ofProduct inAsia PacificBiofilms Treatment Market in 2019

According to a new market research study of ‘Asia PacificBiofilms Treatment Market Forecast to 2027 - COVID-19 Impact and Analysis by product, wound, and end-user’ the Asia Pacificbiofilms treatment market is expected to reach US$ 512.60 million in 2027 from US$ 271.40million in 2019. The market is estimated to grow with a CAGR of 8.3% from 2020-2027. The report provides trends prevailing in the Asia Pacificbiofilms treatment market and the factors driving market along with those that act as hindrances.

Based on the product, the Asia Pacificthebiofilms treatment market, is segmentedintodebridement equipment, gauzes and dressings, grafts and matrices, and others. The gauzes and dressingssegment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.Wound dressings like polyacrylate fibers are effective in disrupting the biofilm matrix which further helps in enhancing the efficacy of antimicrobial agents such as silver. After the process of debridement, dressings along with topical agents are used to prevent or disrupt the biofilm on the wound surface. There are several factors which need to be considered before applying it on the wound. The dressing should provide protection to the periwound skin, form an effective bacterial barrier, minimal pain during application and removal, conforming to wound shape, free of toxic or irritant extractable and dressings that does not release particles or fibers in to the wound. Many companies are developing advanced dressings to prevent biofilms. For instance, ConvaTec Inc. has developed Hydrofiber Technology where the soft absorbent material of the dressing forms gel when it comes in contact with wound fluid. This technology reduces the dead space where bacteria can grow and also provides rapid and sustained antimicrobial activity. Furthermore, gauzes are available in woven and nonwoven forms which have high absorbency and can be applied on both infected as well as non-infected wounds.

The growth of this market is estimated to grow owing to key driving factors such as the rapid technological advancements and new market players and the increasing incidences of diabetic foot ulcers due to rising cases of diabetes. However, the market is expected experiencing slow growth during the forecast period owing to antibiotic-drug resistance issue associated with biofilms treatment.

Coloplast Group, MiMedx, ConvaTec Group Plcare among the leading companies operating in the Asia Pacificbiofilms treatment market. 

The report segments Asia PacificBiofilms Treatment Market as Follows:

By Product

• Gauzes and Dressings
• Debridement Equipment
• Grafts and Matrices
• Others

By Wound

• Traumatic and Surgical Wounds
• Diabetic Foot Ulcers
• Pressure Ulcers
• Venous Leg Ulcers
• Others

By End User

• Hospitals
• Home Care Settings
• Others

By Country

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific